198 related articles for article (PubMed ID: 2471718)
1. SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis.
Storms WW; Bodman SF; Nathan RA; Chervinsky P; Banov CH; Dockhorn RJ; Jarmoszuk I; Zeitz HJ; McGeady SJ; Pinnas JL
J Allergy Clin Immunol; 1989 Jun; 83(6):1083-90. PubMed ID: 2471718
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis.
Bronsky E; Boggs P; Findlay S; Gawchik S; Georgitis J; Mansmann H; Sholler L; Wolfe J; Meltzer E; Morris R
J Allergy Clin Immunol; 1995 Aug; 96(2):139-47. PubMed ID: 7636050
[TBL] [Abstract][Full Text] [Related]
3. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.
Georgitis JW; Meltzer EO; Kaliner M; Weiler J; Berkowitz R
Ann Allergy Asthma Immunol; 2000 Apr; 84(4):451-9. PubMed ID: 10795655
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis.
Prevost M; Turenne Y; Moote DW; Mazza J; Clermont A; PetitClerc C; Danzig MR
Clin Ther; 1994; 16(1):50-6. PubMed ID: 7911402
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.
Chervinsky P; Nayak A; Rooklin A; Danzig M
Allergy Asthma Proc; 2005; 26(5):391-6. PubMed ID: 16450574
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis.
Kaiser HB; Banov CH; Berkowitz RR; Bernstein DI; Bronsky EA; Georgitis JW; Mendelson LM; Rooklin AR; Sholler LJ; Stricker WW; Harrison JE; Danzig MR; Lorber RR
Am J Ther; 1998 Jul; 5(4):245-51. PubMed ID: 10099066
[TBL] [Abstract][Full Text] [Related]
7. Controlled comparison of anew antihistamine-decongestant combination to its individual components.
Falliers CJ; Redding MA
Ann Allergy; 1980 Aug; 45(2):75-80. PubMed ID: 6157338
[TBL] [Abstract][Full Text] [Related]
8. Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis.
Grossman J; Bronsky EA; Lanier BQ; Linzmayer MI; Moss BA; Schenkel EJ; Selner JC
Ann Allergy; 1989 Oct; 63(4):317-21. PubMed ID: 2529798
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis.
Sussman GL; Mason J; Compton D; Stewart J; Ricard N
J Allergy Clin Immunol; 1999 Jul; 104(1):100-6. PubMed ID: 10400846
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
Pleskow W; Grubbe R; Weiss S; Lutsky B
Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the efficiency and safety of the loratadine with pseudoephedrine combination drug in treatment of seasonal allergic rhinitis].
Zawisza E; Lipiec A; Rapiejko P
Pol Merkur Lekarski; 1998 Feb; 4(20):66-8. PubMed ID: 9634291
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
13. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
Berkowitz RB; Woodworth GG; Lutz C; Weiler K; Weiler J; Moss M; Meeves S
Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis.
Del Carpio J; Kabbash L; Turenne Y; Prevost M; Hebert J; Bedard PM; Nedilski M; Gutkowski A; Schulz J
J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):741-6. PubMed ID: 2572617
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
Grubbe RE; Lumry WR; Anolik R
J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the side effects between pseudoephedrine in Loratadine plus Pseudoephedrine Sulfate Repetabs Tables and loratadine + pseudoephedrine tablet in treatment of allergic rhinitis in Thai patients.
Supiyaphun P; Chochaipanichnon L; Kerekhanjanarong V; Saengpanich S
J Med Assoc Thai; 2002 Jun; 85(6):722-7. PubMed ID: 12322847
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of loratadine and azatadine in the treatment of seasonal allergic rhinitis.
Katelaris C
Asian Pac J Allergy Immunol; 1990 Dec; 8(2):103-7. PubMed ID: 1982614
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar.
Williams BO; Hull H; McSorley P; Frosolono MF; Sanders RL
Ann Allergy Asthma Immunol; 1996 May; 76(5):432-8. PubMed ID: 8630717
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of the nonsedating antihistamine loratadine plus pseudoephedrine in the symptomatic management of the common cold.
Berkowitz RB; Connell JT; Dietz AJ; Greenstein SM; Tinkelman DG
Ann Allergy; 1989 Oct; 63(4):336-9. PubMed ID: 2529799
[TBL] [Abstract][Full Text] [Related]
20. Loratadine (SCH29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of seasonal allergic rhinitis.
Bruttmann G; Pedrali P
J Int Med Res; 1987; 15(2):63-70. PubMed ID: 2884152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
